Comparing Sugammadex and Neostigmine for Muscle Relaxant Reversal After Lung Surgery
Official title: An Observational Study on the Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic Surgery
Run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine · NCT06334562 · Data updated 2026-11-12
This study is testing whether sugammadex or neostigmine works better to help patients recover from muscle relaxants after lung surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 75 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | The Fourth Affiliated Hospital of Zhejiang University School of Medicine Academic / other |
| Locations | 1 site (Yiwu, Zhejiang) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | February 17, 2025 |
| Trial ID | NCT06334562 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old undergoing elective lung surgery requiring general anesthesia and endotracheal intubation.
✕Probably not a fit
Patients with severe comorbidities or contraindications to the study medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares the effectiveness of sugammadex sodium and neostigmine in reversing neuromuscular blockade after thoracic surgery. Patients undergoing elective lung surgery under general anesthesia will receive either sugammadex or neostigmine after the administration of rocuronium bromide. The study will monitor recovery times of neuromuscular function and extubation, providing insights into optimizing muscle relaxant use during anesthesia. Data on dosage and recovery will be meticulously recorded to evaluate the outcomes of each reversal agent.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery times and safety for patients undergoing thoracic surgery.
How similar studies have gone: Previous studies have shown promising results with sugammadex in reversing neuromuscular blockade, indicating that this approach is supported by existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients who undergo elective lung surgery under general anesthesia and require endotracheal intubation; 2. Age\>18 years old, gender not limited; 3. American Society of Anesthesiologists ASA Level I-III; 4. Use rocuronium bromide for neuromuscular blockade; 5. The patient voluntarily participated in the trial. Exclusion Criteria: 1. The patient explicitly refused to participate in this trial; 2. Family history of malignant hyperthermia, patients with allergies to sodium sulbactam, neostigmine ingredients and their excipients, and patients with allergies to drugs used during general anesthesia; 3. Patients with tracheal malformations or suspected difficult airways, coagulation dysfunction, severe liver and kidney dysfunction, and severe lung disease; 4. Patients who are not extubated and sent to the ward or ICU after surgery; 5. The researchers believe that patients with any other unfavorable factors to participate in this trial.
Where it's running
-
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Yiwu, Zhejiang, China Recruiting
Study contacts
- Principal investigator: JianHong Xu — The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Study coordinator: JianHong Xu
- Email: xujh1969@163.com
- Phone: 86-18867961109
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NMTCuff vs standard TOF monitoring during gynecologic oncology surgery
This study tests whether NMTCuff monitoring can better detect neuromuscular recovery than standard TOF monitoring in women undergoing laparoscopic gynecologic cancer surgery.
-
HRS-9190 vs Rocuronium for Muscle Relaxation During Anesthesia
This Phase 3 trial tests whether HRS-9190 can provide effective muscle relaxation for intubation and surgery as compared with rocuronium in adults undergoing elective general anesthesia.
-
Two EMG Monitors for Deep NMB During Robotic/Thoracic Surgery
This study tests whether two quantitative EMG monitors (TetraGraph and TwitchView) can better maintain deep neuromuscular blockade during abdominal and thoracic surgery by comparing diaphragmatic movements and breath-initiation events in the same patient.
-
Low-Dose Rocuronium Maintenance During Spine Surgery With Intraoperative Monitoring
This study tests whether keeping a low, controlled amount of rocuronium during spine surgery helps nerve monitoring while improving the surgical field compared to stopping rocuronium after induction.
-
Safer muscle relaxant and reversal choice during anesthesia for people with chronic kidney disease
This trial will try to see if using cisatracurium with neostigmine leads to fewer breathing problems after surgery than using rocuronium with sugammadex in adults who have chronic kidney disease.
-
Comparing muscle responses for monitoring neuromuscular function after surgery
This study is testing a device to see if it can better monitor muscle function after surgery for patients who have received a specific muscle relaxant.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.